Clockwise from top left: Jonathan Cohen, Stephen Elledge, David Ginty, George King, Judy Lieberman, Sharon-Lise Normand
Six Harvard Medical School researchers in the Blavatnik Institute and at affiliated hospitals were among 416 individuals to be elected Fellows of the American Association for the Advancement of Science (AAAS), recognizing their efforts toward advancing science applications that are deemed scientifically or socially distinguished.
Being elected a AAAS Fellow is an honor given to AAAS members by their peers. The new Fellows from HMS are:
Jonathan Cohen, the Bullard Professor of Neurobiology at HMS, was elected to the neuroscience section for contributions to our understanding of cholinergic and GABAergic receptors’ structure and function.
Stephen Elledge, the HMS Gregor Mendel Professor of Genetics and of Medicine at Brigham and Women’s Hospital, was elected to the medical sciences section for significant discoveries in the area of genetics, including the processes of cell self-repair and the function of “watchdog” protein-enzymes.
David Ginty, the Edward R. and Anne G. Lefler Professor of Neurobiology at HMS, was elected to the neuroscience section for distinguished contributions to molecular and cellular neuroscience, particularly the development and function of the neural circuits underlying the perception of touch and pain.
George King, HMS professor of medicine at Joslin Diabetes Center, was elected to the biological studies section for elucidating a role of protein kinase C activation in the development of vascular disease in diabetes, which suggests targets for intervention.
Judy Lieberman, HMS professor of pediatrics at Boston Children’s Hospital, was elected to the biological studies section for studies of molecular pathways activated by granzymes, proteases released by cytotoxic T lymphocytes that induce programmed cell death; also for targeted RNAi therapeutics.
Sharon-Lise Normand, the S. James Adelstein Professor of Health Care Policy at HMS, was elected to the statistics section for distinguished contributions to statistical methodology for profiling health care providers and evidence synthesis, and for impactful collaborations and leadership in cardiovascular disease and health policy.
New Fellows will be presented with an official certificate and a gold and blue (representing science and engineering, respectively) rosette pin in February at the AAAS Fellows Forum during the 2019 AAAS Annual Meeting in Washington, D.C.
Adapted from a AAAS news release.
